KUALA LUMPUR, Oct 28 \u2014 The Malaysian Medical Association (MMA) today urged the Malaysian Medical Council (MMC) to issue an ethical advisory that addresses payer interference in doctors\u2019 clinical decisions.<\/p>\n
The doctors\u2019 group, led by MMA president Dr R. Arasu, met with the MMC Ethics Committee yesterday to raise ethical issues affecting doctors in private health care. The meeting was chaired by Dr Lim Joo Kiong on behalf of the ethics committee under the regulator of the medical profession.<\/p>\n
\u201cMMA urges the Council to issue an updated ethical advisory that addresses blacklisting practices, administrative interference in clinical care, the ethical use of telemedicine, and the appropriate roles of doctors within insurer organisations,\u201d said Dr Arasu in a statement.<\/p>\n
\u201cThis guidance is essential to clarify boundaries, restore clinical confidence, and protect patient welfare in a health care environment that is rapidly changing.\u201d<\/p>\n
He said among the most pressing issues raised at MMA\u2019s meeting with the MMC Ethics Committee was the growing trend of non-clinical interference in patient management decisions.<\/p>\n
\u201cDoctors report being subjected to administrative instructions from insurers and managed care organisations (MCOs) that limit the scope of medical investigations, delay appropriate treatments, or restrict referrals \u2013 all decisions that should rightly fall within the clinical judgement of the treating doctor,\u201d said Dr Arasu.<\/p>\n
MMA highlighted the practice by insurers and takaful operators (ITOs) and MCOs or third-party administrators (TPAs) to blacklist doctors from insurer or corporate panels, allegedly without clear justification or due process.<\/p>\n
The doctors\u2019 group claimed that such exclusions were often driven by commercial interests, rather than ethical considerations.<\/p>\n
\u201cThese decisions not only damage a doctor\u2019s professional reputation but more alarmingly, they compromise the rights of patients, especially insured individuals, by restricting their access to trusted general practitioners or specialists,\u201d said Dr Arasu.<\/p>\n
\u201cEthical exclusion from practice is a serious matter that must only be determined through a professional process under the jurisdiction of the Malaysian Medical Council. The MMC is the only body empowered by law to determine whether a doctor is fit to practise, based on ethical and professional standards.\u00a0<\/p>\n
\u201cEthical regulation must never be outsourced to commercial hands.\u201d<\/p>\n
MMA also raised the issue of clinical circulars and treatment restrictions issued by peer doctors in administrative roles within insurers or TPAs.<\/p>\n
\u201cThese directives often carry clinical weight without the administrative doctor being directly responsible for patient outcomes. This not only blurs accountability but undermines the treating doctor\u2019s duty to act in the best interest of the patient,\u201d said Dr Arasu.<\/p>\n
\u201cSuch practices introduce moral hazard and dilute the trust and clarity that must exist in clinical decision-making. Doctors working with insurers or MCOs are still bound by MMC\u2019s ethical guidelines and must avoid conflicts of interest that compromise patient care.\u201d<\/p>\n
The MMA delegation voiced the deep frustration of many private practitioners who are expected to be accountable for patient outcomes, while having little authority over the care decisions they are permitted to make.\u00a0<\/p>\n
\u201cThe imbalance between responsibility and authority is growing, and with it, the risk of compromised care and declining morale within the medical profession.\u201d<\/p>\n
According to Dr Arasu, the MMC Ethics Committee acknowledged the seriousness of these concerns and has undertaken to present them to the full MMC Council.<\/p>\n
Besides calling for a new ethical advisory that addresses doctor blacklisting practices and ITO or TPA interference in clinical decision-making, MMA urged the MMC to take an active role in the national Grievance Mechanism Committee (GMC) led by Bank Neegara Malaysia to resolve insurance disputes.<\/p>\n
\u201cThe Council\u2019s involvement in this platform is vital to ensure that ethical complaints are addressed at the appropriate level, and not left solely to commercial dispute resolution.\u201d<\/p>\n
MMA acknowledged potential legal gaps in the Medical Act 1971 to regulate ITOs and TPAs, but stressed that this cannot be a reason for inaction.<\/p>\n
\u201cWhere the law falls short of protecting ethical practice and patient rights, the MMA urges the Council to take a leadership role in advocating for legal reform. A future-ready health care system must be supported by a future-ready regulatory framework.\u201d<\/p>\n